MedPath

ASAN FOUNDATION

ASAN FOUNDATION logo
🇰🇷South Korea
Ownership
Private
Established
1989-06-23
Employees
501
Market Cap
-
Website
https://ails.amc.seoul.kr

Effect of Bisoprolol on Progression of Aortic Stenosis

Phase 4
Terminated
Conditions
Aortic Stenosis
Interventions
Drug: placebo
First Posted Date
2012-04-17
Last Posted Date
2018-06-27
Lead Sponsor
Asan Medical Center
Target Recruit Count
20
Registration Number
NCT01579058
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Optimal Number of To-and-fro Motion in EUS-guided Fine Needle Aspiration for Pancreatic Masses

Phase 3
Completed
Conditions
Pancreatic Masses
Interventions
Procedure: EUS-FNA
Device: EUS-FNA with suction
Device: EUS-FNA without suction
First Posted Date
2012-04-12
Last Posted Date
2014-05-29
Lead Sponsor
Asan Medical Center
Target Recruit Count
193
Registration Number
NCT01576497
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis

Not Applicable
Terminated
Conditions
Hemophagocytic Lymphohistiocytosis
Interventions
Drug: IST and/or alloHCT
First Posted Date
2012-03-07
Last Posted Date
2018-07-20
Lead Sponsor
Asan Medical Center
Target Recruit Count
12
Registration Number
NCT01547143
Locations
🇰🇷

Asan Medical center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI

Phase 2
Active, not recruiting
Conditions
Gastrointestinal Stromal Tumors
Interventions
First Posted Date
2012-03-01
Last Posted Date
2024-01-02
Lead Sponsor
Asan Medical Center
Target Recruit Count
23
Registration Number
NCT01541709
Locations
🇰🇷

Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer

Phase 1
Completed
Conditions
Stage IV Gastric Cancer With Metastasis
Interventions
Other: Docetaxel
First Posted Date
2012-02-03
Last Posted Date
2015-06-29
Lead Sponsor
Asan Medical Center
Target Recruit Count
37
Registration Number
NCT01525771
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Second Bowel Preparation for Colonoscopy Failure

Phase 4
Terminated
Conditions
Colonoscopy Failure
Poor Bowel Preparation
Interventions
Drug: polyethylene glycol, Bisacodyl
First Posted Date
2012-01-18
Last Posted Date
2013-02-13
Lead Sponsor
Asan Medical Center
Target Recruit Count
150
Registration Number
NCT01510977
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

First Line Gefitinib by FDG-PET Metabolic Response

Phase 2
Conditions
Non-small Cell Lung Cancer
Interventions
First Posted Date
2012-01-18
Last Posted Date
2013-01-29
Lead Sponsor
Asan Medical Center
Target Recruit Count
60
Registration Number
NCT01510990
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors

Phase 1
Conditions
Acute Leukemia
Myelodysplastic Syndrome
Solid Tumors
Interventions
Biological: anti-thymocyte globulin
Biological: filgrastim
Radiation: Total body irradiation
First Posted Date
2012-01-13
Last Posted Date
2012-01-13
Lead Sponsor
Asan Medical Center
Target Recruit Count
10
Registration Number
NCT01509300
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Prospective Registry of Patients With Isolated Severe Tricuspid Regurgitation

Completed
Conditions
Tricuspid Regurgitation
First Posted Date
2011-12-30
Last Posted Date
2021-02-02
Lead Sponsor
Asan Medical Center
Target Recruit Count
131
Registration Number
NCT01502462
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve

Phase 4
Completed
Conditions
Hypertension
Cardiovascular Risk Factors
Interventions
First Posted Date
2011-12-13
Last Posted Date
2014-05-09
Lead Sponsor
Asan Medical Center
Target Recruit Count
56
Registration Number
NCT01490398
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath